BMC Rheumatology welcomes submissions on all rheumatological diseases, but it places a special emphasis on articles on systemic and inflammatory conditions and connective tissue diseases, and related comorbidities, including cardiovascular disease, malignancy and infection.
Aims and scope
BMC Rheumatology is an open access, peer-reviewed journal that considers pre-clinical, translational and clinical articles on all aspects of the prevention, treatment and management of rheumatological diseases, related systemic and inflammatory conditions and associated comorbidities, as well as epidemiology, education, pathophysiology, genetics, and drug development.
All articles published by BMC Rheumatology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in BMC Rheumatology you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. BMC Rheumatology therefore levies an article-processing charge of £1060.00/$1570.00/€1290.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
For more information on APCs please see our Journal Pricing FAQs
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink. We have succesfully been indexed on DOAJ, EMBASE, PubMed Central, SCOPUS, and Web of Science to ensure that articles published in BMC Rheumatology are available in their database when appropriate. We are working closely with Web of Science (Clarivate Analytics) to establish Impact Factor tracking.
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
In cases where the journal is unable to find sufficient peer reviewers, the services of a publishing partner, Research Square, may be used to identify suitable reviewers and provide reports to avoid further delays for authors. Reviewers recruited by Research Square are paid a small honorarium for completing the review within a specified timeframe. Honoraria are paid regardless of the reviewer recommendation. With Research Square, a double-blind peer review system is in operation.
In cases where reports have been obtained by Research Square, the peer review reports will be unsigned unless the reviewer opts in to sign the report.
BMC Rheumatology operates a transparent peer-review system, where, if the article is published, the reviewer reports are published online alongside the article under a Creative Commons Attribution License 4.0 but the reviewer is not named.
The benefit of transparent peer review is that it increases transparency. In addition, published reports can serve an educational purpose in helping facilitate training and research into peer review.
Manuscripts submitted to BMC Rheumatology are assessed by our editors. All published articles are peer-reviewed. Overall editorial responsibility for the journal is with the Editor with Editorial Board Members acting as handling editors.
BMC Rheumatology is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We do not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field.
Specific criteria for other article types can be found in the submission guidelines.
All manuscripts submitted to BMC Rheumatology should adhere to BMC's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appeals and complaints
Citing articles in BMC Rheumatology
Articles in BMC Rheumatology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. BMC Rheumatol [year], [volume number]:[article number].
e.g. [insert full example] Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. BMC Rheumatol 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Benefits of publishing with BMC
BMC Rheumatology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
BMC Rheumatology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in BMC Rheumatology gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in BMC Rheumatology are included in article alerts and regular email updates. Some may be highlighted on BMC Rheumatology’s pages and on the BMC homepage.
In addition, articles published in BMC Rheumatology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in BMC Rheumatology. A list of articles recently press-released by journals published by BMC is available here.
As an author of an article published in BMC Rheumatology you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).
For further information about the advantages of publishing in a journal from BMC, please click here.